Data / Drug companies / Curia Italy S.r.l.
Curia Italy S.r.l.: 33 products in the FDA NDC directory, labeler code 55486
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Curia Italy S.r.l. (labeler code 55486) lists 33 products in the FDA National Drug Code Directory. By type: 33 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 19, 2024.
The request: Watch Curia Italy S.r.l. (FDA labeler code 55486): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 55486
- Products in commercial distribution
- 33
- Packages
- 33
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule III 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- July 31, 1990
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 33 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 33 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 32 | 97% |
| Liquid | 1 | 3% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Aceclidine hcl | 55486-1608 | Powder | Bulk ingredients | September 19, 2024 |
| Nyprg-101 | 55486-1605 | Powder | Bulk ingredients | September 14, 2023 |
| Cyclosporine | 55486-1604 | Powder | Bulk ingredients | November 4, 2021 |
| Argatroban monohydrate | 55486-1607 | Powder | Bulk ingredients | March 23, 2015 |
| Dihydroergotamine mesylate | 55486-1599 | Powder | Bulk ingredients | December 23, 2014 |
| Citalopram hydrochloride | 55486-1598 | Powder | Bulk ingredients | July 3, 2012 |
| Rocuronium bromide | 55486-1606 | Powder | Bulk ingredients | June 3, 2012 |
| Cyclosporine | 55486-1603 | Powder | Bulk ingredients | June 3, 2012 |
| Cyclosporine | 55486-1602 | Powder | Bulk ingredients | June 3, 2012 |
| Atracurium besylate | 55486-1597 | Powder | Bulk ingredients | June 3, 2012 |
| Rocuronium bromide | 55486-1593 | Powder | Bulk ingredients | June 3, 2012 |
| Sirolimus complex | 55486-1592 | Powder | Bulk ingredients | June 3, 2012 |
| Sodium mycophenolate | 55486-1591 | Powder | Bulk ingredients | June 3, 2012 |
| Donepezil hydrochloride | 55486-1590 | Powder | Bulk ingredients | June 3, 2012 |
| Dihydroergotamine mesylate | 55486-1587 | Powder | Bulk ingredients | June 3, 2012 |
| Pimecrolimus | 55486-1585 | Powder | Bulk ingredients | June 3, 2012 |
| Argatroban | 55486-1582 | Powder | Bulk ingredients | June 3, 2012 |
| Ergotamine tartrate | 55486-1581 | Powder | Bulk ingredients | June 3, 2012 |
| Tacrolimus | 55486-1576 | Powder | Bulk ingredients | June 3, 2012 |
| Azelastine hydrochloride | 55486-1575 | Powder | Bulk ingredients | June 3, 2012 |
| Ergoloid mesylates | 55486-1574 | Powder | Bulk ingredients | June 3, 2012 |
| Citalopram hydrobromide | 55486-1572 | Powder | Bulk ingredients | June 3, 2012 |
| Sirolimus | 55486-1571 | Powder | Bulk ingredients | June 3, 2012 |
| Oxandrolone | 55486-1570 | Powder | Bulk ingredients | June 3, 2012 |
| Pancuronium bromide | 55486-1568 | Powder | Bulk ingredients | June 3, 2012 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.